These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34757740)

  • 21. Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation/reoxygenation injury: Involvement of inhibiting autophagy via class I PI3K/Akt/mTOR signaling pathway.
    Yang G; Wang N; Seto SW; Chang D; Liang H
    Brain Res Bull; 2018 Jun; 140():243-257. PubMed ID: 29775658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism.
    Liu J; Yue S; Yang Z; Feng W; Meng X; Wang A; Peng C; Wang C; Yan D
    Pharmacol Res; 2018 Aug; 134():40-50. PubMed ID: 29787870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intragastric safflower yellow and its main component HSYA improve leptin sensitivity before body weight change in diet-induced obese mice.
    Lyu X; Yan K; Xu H; Zhu H; Pan H; Wang L; Yang H; Gong F
    Naunyn Schmiedebergs Arch Pharmacol; 2022 May; 395(5):579-591. PubMed ID: 35201390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice.
    Min F; Sun H; Wang B; Ahmad N; Guo H; Gao H; Gao Y; Liu X; Li H
    Eur J Pharmacol; 2020 Aug; 881():173214. PubMed ID: 32454116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxysafflor yellow A (HSYA) targets the platelet-activating factor (PAF) receptor and inhibits human bronchial smooth muscle activation induced by PAF.
    Guo X; Zheng M; Pan R; Zang B; Gao J; Ma H; Jin M
    Food Funct; 2019 Aug; 10(8):4661-4673. PubMed ID: 31292579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
    Min J; Wei C
    Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
    Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
    J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxysafflor-Yellow A Induces Human Gastric Carcinoma BGC-823 Cell Apoptosis by Activating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
    Liu L; Si N; Ma Y; Ge D; Yu X; Fan A; Wang X; Hu J; Wei P; Ma L; Chen Z; Zhang Q; Feng C
    Med Sci Monit; 2018 Feb; 24():803-811. PubMed ID: 29417935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
    Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
    Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling.
    Han D; Wei J; Zhang R; Ma W; Shen C; Feng Y; Xia N; Xu D; Cai D; Li Y; Fang W
    Sci Rep; 2016 Oct; 6():35319. PubMed ID: 27731393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation.
    Li J; Zhang S; Lu M; Chen Z; Chen C; Han L; Zhang M; Xu Y
    Neurosci Lett; 2013 Feb; 535():51-6. PubMed ID: 23333598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats.
    Xu RA; Xu ZS; Ge RS
    J Ethnopharmacol; 2014 Feb; 151(3):1141-1146. PubMed ID: 24373810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
    Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways.
    Yu L; Liu Z; He W; Chen H; Lai Z; Duan Y; Cao X; Tao J; Xu C; Zhang Q; Zhao Z; Zhang J
    Cell Mol Neurobiol; 2020 Nov; 40(8):1271-1281. PubMed ID: 32060857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
    Jin M; Wu Y; Wang L; Zang B; Tan L
    Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
    Wu W; Jin M; Tong J; Wang XF; Zang BX
    Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
    Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
    Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
    Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
    Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
    Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
    Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.
    Jiang S; Shi Z; Li C; Ma C; Bai X; Wang C
    Int J Clin Exp Pathol; 2014; 7(5):2595-608. PubMed ID: 24966974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.